MTOR and neoplasm: Different signaling pathways have been reported to be modulated using AdipoRon, irrespective of the tumor type, such as mitogen-activated protein kinases (p42/p44 MAPK), AMPK and the mammalian target of rapamycin (mTOR) [20,21,23].